While most of the molecular studies focus over mutational analysis, epigenetics-is the only science which is gaining momentum with its cheaper and faster technology, by making its way to the clinic. Moving on the path of clinical epigenetics, our 4th Annual MarketsandMarkets Epigenetics Congress will discuss the solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis.

The conference is scheduled on 3rd & 4th October 2019, London-UK, which is one of the unique platform to witness epigenetics based clinical development and combinational therapies, with a special emphasis on transcriptional analysis and molecular profiling.

Key Highlights

Epigenetic modification | Genomic profiling | Transcriptional mechanism | Molecular inhibitors | Epigenetic modulators | Clinical applications of epigenetics

Who should attend?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical and Research Institutes
working in:

Epigenetics | Developmental Epigenetics | Epidemiology | Molecular Biology | Developmental Biology | Biological Sciences | Biochemistry | Medicinal Chemistry | Pharmaceutical chemistry | Genetics and Genomics | Developmental Genetics | Translational sciences/medicines